$1.03
Quote Sep 15, 2026, 08:00 PM UTC
−90.84%over the last month
Max drawdown −94.4%From 1-month high −91.8%3 months −94.3%
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield.
Sector
Healthcare
Industry
Medical - Specialties
Exchange
NASDAQ
Employees
13
Market value
$11.4M
Quote Sep 15
Analyst target
$4.65
+351.5% from here
Floor
$0.97
6.1% below price
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free